Comparison of Pentoxiphylline alone against Pentoxiphylline and N acetyl cysteine in Severe alcoholic hepatitis
Phase 2
Completed
- Conditions
- Health Condition 1: null- Patients with severe alcoholic hepatitis
- Registration Number
- CTRI/2018/03/012577
- Lead Sponsor
- Dr Deepak Suvarna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 240
Inclusion Criteria
Patients with severe alcoholic hepatitis ie patients with Maddrey DF more than 32
Exclusion Criteria
Hepatic encephalopathy hepatorenal syndrome GI bleed sepsis multiorgan dysfunction Viral hepatitis autoimmune hepatitis drug induced hepatitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival of patients between two groupsTimepoint: At ninety days
- Secondary Outcome Measures
Name Time Method FT PT INRTimepoint: At thirty and ninety days